You searched for "Colorectal" from the Body Image.

Stage	Phase	Principal Investigator	Study prefix	Study number	Title (click hyperlink for more information)
		Marwan Fakih, MD	I	99207	Identification of 24-Hydroxylase Polymorphisms and Splicing Variants that Modulate Vitamin D Oxidative Metabolism and Serum Pharmacokinetics in Patients with Colorectal Cancer on Cholecalciferol Therapy (CLOSED with TREATMENT)
	I	Marwan Fakih, MD	I	55305	A Phase I Study of Suberoylanilide Hydroxamic Acid (SAHA, Vorinostat) in Combination with 5-Fluorouracil, Leucovorin and Oxaliplatin (FOLFOX) in Patients with Colorectal Cancer and other Solid Tumors(NCI#6789)
II and III	II	Marwan Fakih, MD	I	113607	A Phase II Study of Capecitabine, Oxaliplatin and Selenomethionine and Radiation Therapy in Patients with Stage II and III Rectal Adenocarcinoma
	Pilot	Annette Sunga, MD	I	131908	Pilot Study of a Multicenter, Telephone-Based Exercise Intervention for Patients with Early Stage Breast and Colorectal Cancer: The Activity After Cancer Trial (AACT)
	II	Marwan Fakih, MD	I	152009	( CA225-324) A Phase II Study of High Dose Cetuximab Plus Irinotecan in Colorectal Cancer Patients with KRAS-Wild Tumors who Progressed After failure of Prior Standard Dose of Cetuximaib Plus Irinotecan
III	III	Marwan Fakih, MD	NCG	100107	(NCCTG N0147) A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) With or Without Cetuximab (C225) After Curative Resection for Patients with Stage III Colon Cancer
		Gary Yang, MD	I	128808	Intensity Modulated Radiation Therapy for Anal Cancer: Dosimetric Comparison, Acute Toxicity Profile, and Quality of Life Assessment
	II	Marwan Fakih, MD	I	142808	A Randomized Phase II Study of Two Dose-Levels of Vorinstat in Combination with 5-FU and Leucovorin in Patients with Refractory Metastatic Colorectal Cancer

Total number of Clinical Trials found: 8

Return to Search page